Fundz

Emmes Acquires Casimir, Its Fourth Major Acquisition

PRIVATEMar 10, 2022

Acquiring Company

Emmes

Acquired Company

Casimir

RockvilleBiotechnologyHealth CareScience And EngineeringArtificial IntelligenceGovernment And MilitaryHealth Care

Description

Emmes (the "Company"), a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation and a portfolio company of Behrman Capital, today announced that it has acquired Casimir. A U.S.-based CRO, Casimir has experience in more than 20 rare diseases and has worked with regulators, sponsors and patients to develop outcome measures that capture the nuances of disease progression and treatment benefit. Terms of the transaction were not disclosed.

Quick answer

Emmes is acquiring Casimir, announced March 10, 2022. Emmes is based in Rockville, Maryland, United States.

How much did Emmes pay for Casimir?
The deal value was not disclosed.
What does Emmes do?
Emmes, founded more than 45-years ago, is a global, full-service Clinical Research Organization (CRO) dedicated to the advancement of public health and biopharmaceutical innovation.
Where are Emmes and Casimir based?
Emmes is based in Rockville, Maryland, United States.
Who are the decision-makers at Emmes?
Fundz holds 1 contact at Emmes. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Other recent acquisitions in Science And Engineering and Government And Military

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Emmes, and when

When Emmes changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Emmes raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Emmes, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Emmes. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Emmes

Location

Rockville, Maryland, United States

About

Emmes, founded more than 45-years ago, is a global, full-service Clinical Research Organization (CRO) dedicated to the advancement of public health and biopharmaceutical innovation. Emmes has supported more than 2,000 clinical trials across numerous agencies and institutes of the U.S. federal government and a wide range of biotechnology, pharmaceutical and medical device companies throughout the world. The company has built industry leading capabilities in cell and gene therapy, vaccines and infectious diseases, ophthalmology, and neuroscience. Today, we are part of the Emmes Group, helping transform the future of clinical research.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Emmes makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Peter
Likely contact at this company
••••••••@••••••••

See Peter's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Emmes's next move

Learn about Strategic plan

Frequently asked

Who acquired Casimir?

Casimir was acquired by Emmes, based in Rockville. The deal was reported on March 10, 2022. Emmes, founded more than 45-years ago, is a global, full-service Clinical Research Organization (CRO) dedicated to the advancement of public health and biopharmaceutical innovation. Emmes is privately held and operates in Biotechnology.

When did Emmes acquire Casimir?

Emmes's acquisition of Casimir was reported on March 10, 2022. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Casimir do?

It is privately held, operating in Health Care.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.